| abstract |
The invention provides a class of 5HT6--D3/DAT compounds, packaged pharmaceuticals comprising such compounds, and their uses in treating, or the manufacturing medicaments for treating disease conditions, inlcuding a movement disorder, anxiety, depression or psychotic disorder (e.g. Bipolar Disorder, Bipolar Depression or Unipolar Depression, etc.). Related business methods such as marketing the compounds to healthcare providers are also provided. |